222 related articles for article (PubMed ID: 24677715)
1. A novel function of microRNA 130a-3p in hepatic insulin sensitivity and liver steatosis.
Xiao F; Yu J; Liu B; Guo Y; Li K; Deng J; Zhang J; Wang C; Chen S; Du Y; Lu Y; Xiao Y; Zhang Z; Guo F
Diabetes; 2014 Aug; 63(8):2631-42. PubMed ID: 24677715
[TBL] [Abstract][Full Text] [Related]
2. Hepatic exosome-derived miR-130a-3p attenuates glucose intolerance via suppressing PHLPP2 gene in adipocyte.
Wu J; Dong T; Chen T; Sun J; Luo J; He J; Wei L; Zeng B; Zhang H; Li W; Liu J; Chen X; Su M; Ni Y; Jiang Q; Zhang Y; Xi Q
Metabolism; 2020 Feb; 103():154006. PubMed ID: 31715176
[TBL] [Abstract][Full Text] [Related]
3. Elevated Hepatic miR-22-3p Expression Impairs Gluconeogenesis by Silencing the Wnt-Responsive Transcription Factor Tcf7.
Kaur K; Vig S; Srivastava R; Mishra A; Singh VP; Srivastava AK; Datta M
Diabetes; 2015 Nov; 64(11):3659-69. PubMed ID: 26193896
[TBL] [Abstract][Full Text] [Related]
4. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
Wang Y; Du J; Niu X; Fu N; Wang R; Zhang Y; Zhao S; Sun D; Nan Y
Cell Death Dis; 2017 May; 8(5):e2792. PubMed ID: 28518142
[TBL] [Abstract][Full Text] [Related]
5. Mir-338-3p Mediates Tnf-A-Induced Hepatic Insulin Resistance by Targeting PP4r1 to Regulate PP4 Expression.
Dou L; Wang S; Sun L; Huang X; Zhang Y; Shen T; Guo J; Man Y; Tang W; Li J
Cell Physiol Biochem; 2017; 41(6):2419-2431. PubMed ID: 28467989
[TBL] [Abstract][Full Text] [Related]
6. Liver MicroRNA-291b-3p Promotes Hepatic Lipogenesis through Negative Regulation of Adenosine 5'-Monophosphate (AMP)-activated Protein Kinase α1.
Meng X; Guo J; Fang W; Dou L; Li M; Huang X; Zhou S; Man Y; Tang W; Yu L; Li J
J Biol Chem; 2016 May; 291(20):10625-34. PubMed ID: 27013659
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p.
Zhang B; Li H; Li D; Sun H; Li M; Hu H
Gene; 2019 Jun; 700():139-148. PubMed ID: 30898698
[TBL] [Abstract][Full Text] [Related]
8. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
9. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
Zhuge B; Li G
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
[TBL] [Abstract][Full Text] [Related]
10. Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid.
Yang YM; Seo SY; Kim TH; Kim SG
Hepatology; 2012 Dec; 56(6):2209-20. PubMed ID: 22807119
[TBL] [Abstract][Full Text] [Related]
11. Hepatic miR-125b inhibits insulin signaling pathway by targeting PIK3CD.
Du X; Li X; Chen L; Zhang M; Lei L; Gao W; Shi Z; Dong Y; Wang Z; Li X; Liu G
J Cell Physiol; 2018 Aug; 233(8):6052-6066. PubMed ID: 29319168
[TBL] [Abstract][Full Text] [Related]
12. Hepatic miR-192-3p reactivation alleviates steatosis by targeting glucocorticoid receptor.
Wang Z; Miu KK; Zhang X; Wan AT; Lu G; Cheung HH; Lee HM; Kong AP; Chan JC; Chan WY
JHEP Rep; 2020 Dec; 2(6):100179. PubMed ID: 33134908
[TBL] [Abstract][Full Text] [Related]
13. Saturated fatty acids-induced miR-424-5p aggravates insulin resistance via targeting insulin receptor in hepatocytes.
Min KH; Yang WM; Lee W
Biochem Biophys Res Commun; 2018 Sep; 503(3):1587-1593. PubMed ID: 30033101
[TBL] [Abstract][Full Text] [Related]
14. High fat diet induced downregulation of microRNA-467b increased lipoprotein lipase in hepatic steatosis.
Ahn J; Lee H; Chung CH; Ha T
Biochem Biophys Res Commun; 2011 Nov; 414(4):664-9. PubMed ID: 21986524
[TBL] [Abstract][Full Text] [Related]
15. Hepatic MiR-291b-3p Mediated Glucose Metabolism by Directly Targeting p65 to Upregulate PTEN Expression.
Guo J; Dou L; Meng X; Chen Z; Yang W; Fang W; Yang C; Huang X; Tang W; Yang J; Li J
Sci Rep; 2017 Jan; 7():39899. PubMed ID: 28054586
[TBL] [Abstract][Full Text] [Related]
16. MiR-130a-3p Inhibits PRL Expression and Is Associated With Heat Stress-Induced PRL Reduction.
Zhang H; Chen T; Xiong J; Hu B; Luo J; Xi Q; Jiang Q; Sun J; Zhang Y
Front Endocrinol (Lausanne); 2020; 11():92. PubMed ID: 32194503
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone Suppresses Palatal Cell Proliferation through miR-130a-3p.
Yoshioka H; Jun G; Suzuki A; Iwata J
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830336
[TBL] [Abstract][Full Text] [Related]
18. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice.
Bijl N; Sokolović M; Vrins C; Langeveld M; Moerland PD; Ottenhoff R; van Roomen CP; Claessen N; Boot RG; Aten J; Groen AK; Aerts JM; van Eijk M
Hepatology; 2009 Nov; 50(5):1431-41. PubMed ID: 19731235
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
Zhang X; Huang L; Zhao Y; Tan W
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
[TBL] [Abstract][Full Text] [Related]
20. miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program.
Su S; Zhao Q; He C; Huang D; Liu J; Chen F; Chen J; Liao JY; Cui X; Zeng Y; Yao H; Su F; Liu Q; Jiang S; Song E
Nat Commun; 2015 Oct; 6():8523. PubMed ID: 26436920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
